A Multimodal Intervention Using Nonopioid Analgesics Is Associated With Reduced Intravenous Opioid Exposure Among Hospitalized Patients With Inflammatory Bowel Diseases

被引:10
作者
Dalal, Rahul S. [1 ]
Palchaudhuri, Sonali [2 ]
Snider, Christopher K. [3 ]
Gitelman, Yevgeniy [4 ]
Brahmbhatt, Mihir [4 ]
Mull, Nikhil K. [4 ]
Mehta, Shivan J. [2 ,3 ]
Klock, Christopher [5 ]
Lewis, James D. [2 ,5 ]
Lichtenstein, Gary R. [2 ]
机构
[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA
[2] Univ Penn, Dept Med, Div Gastroenterol, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Penn Med Ctr Hlth Care Innovat, Philadelphia, PA 19104 USA
[4] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA
[5] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
关键词
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; NARCOTIC USE; ULCERATIVE-COLITIS; PAIN; MULTICENTER; PREVALENCE; CELECOXIB; MORTALITY; RISK;
D O I
10.14309/ajg.0000000000000806
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
INTRODUCTION: Opioid use in patients with inflammatory bowel disease (IBD) is associated with increased mortality. Previous interventions targeting reduced intravenous opioid (IVOPI) exposure for all patients admitted to a general medical unit have decreased total opioid use without compromising pain control. We therefore performed a prospective evaluation of a multimodal intervention encouraging the use of nonopioid alternatives to reduce IVOPI exposure among patients with IBD hospitalized at our institution. METHODS: This was a prospective evaluation of a multimodal intervention to reduce IVOPI use among patients with IBD aged >= 18 years admitted to a general medical unit at a large urban academic medical center from January 1, 2019, to June 30, 2019. Intravenous and total (all routes) opioid exposures were measured as proportions and intravenous morphine milligram equivalents/patient day and compared with preintervention (January 1, 2018, to December 31, 2018) data. Hospital length of stay (LOS), 30-day readmission rates (RRs), and pain scores (1-10 scale) were also assessed. RESULTS: Our study involved 345 patients with IBD with similar baseline characteristics in preintervention (n = 241) and intervention (n = 104) periods. Between study periods, we observed a significant reduction in the proportion of patients receiving IVOPIs (43.6% vs 30.8%,P= 0.03) and total opioid dose exposure (15.6 vs 8.5 intravenous morphine mg equivalents/d,P= 0.02). We observed similar mean pain scores (3.9 vs 3.7,P= 0.55) and significantly reduced mean LOS (7.2 vs 5.3 days,P= 0.03) and 30-day RRs (21.6% vs 11.5%,P= 0.03). DISCUSSION: A multimodal intervention was associated with reduced opioid exposure, LOS, and 30-day RRs for hospitalized patients with IBD. Additional research is needed to determine long-term benefits of reduced opioid exposure in this population.
引用
收藏
页码:1474 / 1485
页数:12
相关论文
共 30 条
[1]   Association of an Opioid Standard of Practice Intervention With Intravenous Opioid Exposure in Hospitalized Patients [J].
Ackerman, Adam L. ;
O'Connor, Patrick G. ;
Doyle, Deirdre L. ;
Marranca, Sheyla M. ;
Haight, Carolyn L. ;
Day, Christine E. ;
Fogerty, Robert L. .
JAMA INTERNAL MEDICINE, 2018, 178 (06) :759-763
[2]   How fast and how often: The pharmacokinetics of drug use are decisive in addiction [J].
Allain, Florence ;
Minogianis, Ellie-Anna ;
Roberts, David C. S. ;
Samaha, Anne-Noel .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2015, 56 :166-179
[3]   Does It Matter Where You Are Hospitalized for Inflammatory Bowel Disease? A Nationwide Analysis of Hospital Volume [J].
Ananthakrishnan, Ashwin N. ;
McGinley, Emily L. ;
Binion, David G. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (11) :2789-2798
[4]   Aspirin, Nonsteroidal Anti-inflammatory Drug Use, and Risk for Crohn Disease and Ulcerative Colitis A Cohort Study [J].
Ananthakrishnan, Ashwin N. ;
Higuchi, Leslie M. ;
Huang, Edward S. ;
Khalili, Hamed ;
Richter, James M. ;
Fuchs, Charles S. ;
Chan, Andrew T. .
ANNALS OF INTERNAL MEDICINE, 2012, 156 (05) :350-U170
[5]  
[Anonymous], 2017, Anesth Pain Med
[6]   The impact of intravenous acetaminophen on pain after abdominal surgery: a meta-analysis [J].
Blank, Jacqueline J. ;
Berger, Nicholas G. ;
Dux, Justin P. ;
Ali, Fadwa ;
Ludwig, Kirk A. ;
Peterson, Carrie Y. .
JOURNAL OF SURGICAL RESEARCH, 2018, 227 :234-245
[7]   Increasing Prescription of Opiates and Mortality in Patients With Inflammatory Bowel Diseases in England [J].
Burr, Nicholas E. ;
Smith, Chris ;
West, Robert ;
Hull, Mark A. ;
Subramanian, Venkataraman .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (04) :534-+
[8]   Narcotic use in patients with Crohn's disease [J].
Cross, RK ;
Wilson, KT ;
Binion, DG .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (10) :2225-2229
[9]   Hospitalization Outcomes for Inflammatory Bowel Disease in Teaching vs Nonteaching Hospitals [J].
Dalal, Rahul S. ;
Vajravelu, Ravy K. ;
Lewis, James D. ;
Lichtenstein, Gary R. .
INFLAMMATORY BOWEL DISEASES, 2019, 25 (12) :1974-1982
[10]  
Dalal RS, 2019, CLIN GASTROENTEROL H